Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOHeart: Low Dose Epoetin Beta in Ischemic Heart Failure
NCT00568542Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- May 2006
- Primary completion
- Oct 2008
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemic cardiomyopathy (ICM) comparing Epoetin Beta with Placebo (2 arms). Primary endpoint: Change in global left ventricular ejection fraction at 6 months. Started May 2006; status: completed.
02
Drugs
epoetin beta
03
Conditions
ischemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on NCT00568542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568542.